MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-05-31, WBA made $38,986M in revenue. -$175M in net income. Net profit margin of -0.45%.

Income Overview

Revenue
$38,986M
Net Income
-$175M
Net Profit Margin
-0.45%
EPS
-$0.2
Unit: Million (M) dollars
Revenue Breakdown
    • Operating Segments-United States...
    • Operating Segments-International...
    • Operating Segments-USHealthcare

Income Statement
2025-05-31
2024-11-30
2024-05-31
2024-02-29
Sales
38,986 39,459 36,351 37,052
Cost of sales
32,480 32,680 29,892 30,012
Gross profit
6,506 6,779 6,460 7,041
Impairments
---12,369
Equity earnings in cencora
40 -9 44 79
Selling, general and administrative expenses
6,493 7,015 6,393 7,921
Operating income (loss)
53 -245 111 -13,171
Other income (expense), net
-2 -171 254 195
Earnings (loss) before interest and income tax provision (benefit)
51 -415 365 -12,976
Interest expense, net
126 122 113 138
Earnings (loss) before income tax provision (benefit)
-75 -538 251 -13,114
Post-tax earnings (loss) from other equity method investments
5 -1 -1 10
Income tax provision (benefit)
126 66 20 -782
Net earnings (loss)
-196 -605 230 -12,322
Net loss attributable to non-controlling interests
-21 -340 -114 -6,415
Net earnings (loss) attributable to walgreens boots alliance, inc
-175 -265 344 -5,908
Basic EPS
-0.2 -0.31 0.4 -6.85
Diluted EPS
-0.2 -0.31 0.4 -6.85
Basic Average Shares
864,900,000 863,800,000 863,100,000 862,500,000
Diluted Average Shares
864,900,000 863,800,000 864,300,000 862,500,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Pharmacy$24,381M (11.78%↑ Y/Y)Retail$6,334M (-5.34%↓ Y/Y)Pharmaceutical Wholesale$3,283M Retail$1,976M (-70.47%↓ Y/Y)Pharmacy$913M (-95.81%↓ Y/Y)OperatingSegments-United States Retail...$30,715M OperatingSegments-International Reportable...$6,172M OperatingSegments-USHealthcare$2,102M Sales$38,986M (7.25%↑ Y/Y)Corporate And ReconcilingItems-$4M Net earnings (loss)attributable to walgreens...-$175M (-150.87%↓ Y/Y)Net lossattributable to...-$21M (81.58%↑ Y/Y)Gross profit$6,506M (0.71%↑ Y/Y)Equity earnings incencora$40M (-9.09%↓ Y/Y)Cost of sales$32,480M (8.66%↑ Y/Y)Net earnings (loss)-$196M (-185.22%↓ Y/Y)Post-tax earnings (loss)from other equity...$5M (600.00%↑ Y/Y)Operating income (loss)$53M (-52.25%↓ Y/Y)Selling, general andadministrative expenses$6,493M (1.56%↑ Y/Y)Income tax provision(benefit)$126M (530.00%↑ Y/Y)Earnings (loss) beforeincome tax provision...-$75M (-129.88%↓ Y/Y)Earnings (loss) beforeinterest and income tax...$51M (-86.03%↓ Y/Y)Other income(expense), net-$2M (-100.79%↓ Y/Y)Interest expense, net$126M (11.50%↑ Y/Y)

Walgreens_Boots_Alliance-svg

Walgreens Boots Alliance, Inc. (WBA)

Walgreens_Boots_Alliance-svg

Walgreens Boots Alliance, Inc. (WBA)